Yield10 Bioscience, Inc. (YTEN)

Market Cap	1.46M
Revenue (ttm)	360,000
Net Income (ttm)	-13.15M
Shares Out	642.54K
EPS (ttm)	-36.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	88,361
Open	2.840
Previous Close	2.880
Day's Range	2.020 - 3.570
52-Week Range	2.000 - 72.960
Beta	1.70
Analysts	Buy
Price Target	54.00 (+1,775.0%)
Earnings Date	May 15, 2024

About YTEN

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscienc...

• Industry: Agricultural Inputs
• Sector: Materials
• IPO Date: Nov 10, 2006
• Employees: 29
• Stock Exchange: NASDAQ
• Ticker Symbol: YTEN

Financial Performance

In 2023, YTEN's revenue was $60,000, a decrease of -86.67% compared to the previous year's $450,000. Losses were -$14.46 million, 6.55% more than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for YTEN stock is "Buy." The 12-month stock price forecast is $54.0, which is an increase of 1,775.00% from the latest price.

Price Target

$54.0

(1,775.00% upside)

Analyst Consensus: Buy